Belantamab mafodotin within the Drug Program B.54 Treatment of patients with plasma cell myeloma - 1 product package
Belantamab mafodotin w ramach realizacji Programu Lekowego B.54 Leczenie chorych na szpiczaka plazmocytowego - 1 pakiet asortymentowy
Poland · Poznań
Contract
BuyerUNIWERSYTECKI SZPITAL KLINICZNY W POZNANIU
TypeSupplies
Estimated valuevalue not published
Published13 July 2026
CategoryMedical equipment & pharma · CPV 33600000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Urtica Sp. z o.o. | 106 | 2024–2026 |
| Asclepios S.A. | 59 | 2024–2026 |
| Komtur Polska Sp. z o.o. | 56 | 2024–2026 |
| Aesculap Chifa Sp. z o.o. · 64-300 PL | 40 | 2023–2026 |
| Bialmed Sp. z o.o. | 37 | 2024–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2024327
2025446
2026383
Who knows the rhythm prepares instead of reacting.
1
days until the deadline — Friday 21 August at 00:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →